Table 3.
Wrinkles evaluation (subtracted values)
|
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
4 weeks of ingestion | 8 weeks of ingestion | 12 weeks of ingestion | 4 weeks after ingestion ended | |||||||||
|
|
|
|
|||||||||
Item | Unit | Area | Group | n | Mean ± SE | p | Mean ± SE | p | Mean ± SE | p | Mean ± SE | p |
Area rate | μm2/mm2/100 | 5 mm | Koji | 34 | 0.072 ± 0.109 | 0.535 | 0.084 ± 0.077 | 0.765 | 0.301 ± 0.087 | 0.574 | 0.134 ± 0.138 | 0.797 |
Placebo | 34 | 0.171 ± 0.114 | 0.048 ± 0.096 | 0.211 ± 0.131 | 0.188 ± 0.154 | |||||||
Volume rate | μm3/mm2/100 | Koji | 34 | 1.87 ± 1.99 | 0.553 | 0.95 ± 1.24 | 0.865 | 5.89 ± 1.92 | 0.730 | 2.19 ± 2.44 | 0.460 | |
Placebo | 34 | 3.61 ± 2.13 | 1.37 ± 2.15 | 4.64 ± 3.03 | 5.17 ± 3.16 | |||||||
Average depth (total wrinkle) | μm | Koji | 34 | 0.551 ± 0.999 | 0.652 | −0.041 ± 0.925 | 0.307 | 3.124 ± 1.305 | 0.669 | 1.775 ± 1.329 | 0.288 | |
Placebo | 34 | 1.234 ± 1.136 | 1.665 ± 1.384 | 2.323 ± 1.330 | 3.709 ± 1.221 | |||||||
Average depth (max wrinkle) | μm | Koji | 34 | 0.675 ± 1.891 | 0.794 | −0.265 ± 1.567 | 0.468 | 3.636 ± 1.925 | 0.914 | 1.919 ± 2.038 | 0.107 | |
Placebo | 34 | 1.378 ± 1.885 | 1.588 ± 2.004 | 3.940 ± 2.021 | 6.750 ± 2.137 | |||||||
Max depth (max wrinkle) | μm | Koji | 34 | 25.365 ± 14.635 | 0.776 | −16.191 ± 10.780 | 0.876 | 9.040 ± 11.749 | 0.805 | 15.867 ± 13.850 | 0.226 | |
Placebo | 34 | 18.872 ± 17.518 | −13.511 ± 13.274 | 13.749 ± 14.984 | 42.092 ± 16.424 | |||||||
Number of wrinkles | N/mm | Koji | 34 | −0.003 ± 0.010 | 0.761 | 0.006 ± 0.009 | 0.327 | 0.007 ± 0.010 | 0.860 | 0.006 ± 0.013 | 0.559 | |
Placebo | 34 | 0.001 ± 0.010 | −0.007 ± 0.009 | 0.005 ± 0.009 | −0.004 ± 0.011 | |||||||
Area rate | μm2/mm2/100 | 10 mm | Koji | 34 | 0.050 ± 0.084 | 0.989 | 0.064 ± 0.080 | 0.617 | 0.254 ± 0.080 | 0.410 | 0.246 ± 0.113 | 0.284 |
Placebo | 34 | 0.052 ± 0.084 | 0.136 ± 0.121 | 0.160 ± 0.082 | 0.095 ± 0.080 | |||||||
Volume rate | μm3/mm2/100 | Koji | 34 | 1.01 ± 1.23 | 0.890 | 0.89 ± 1.13 | 0.530 | 4.34 ± 1.40 | 0.290 | 3.70 ± 1.72 | 0.323 | |
Placebo | 34 | 0.77 ± 1.23 | 2.40 ± 2.13 | 2.34 ± 1.21 | 1.58 ± 1.24 | |||||||
Average depth (total wrinkle) | μm | Koji | 34 | 0.665 ± 0.725 | 0.540 | 0.790 ± 1.062 | 0.726 | 3.214 ± 0.978 | 0.035* | 2.147 ± 1.116 | 0.371 | |
Placebo | 34 | 0.027 ± 0.739 | 1.376 ± 1.290 | 0.378 ± 0.882 | 0.822 ± 0.951 | |||||||
Max depth (total wrinkle) | μm | Koji | 34 | −1.388 ± 6.861 | 0.947 | −9.655 ± 7.375 | 0.395 | 2.577 ± 9.238 | 0.958 | −2.691 ± 6.840 | 0.510 | |
Placebo | 34 | −0.707 ± 7.562 | −0.426 ± 7.884 | 3.220 ± 8.099 | 4.344 ± 8.147 | |||||||
Number of wrinkles | N/mm | Koji | 34 | −0.006 ± 0.011 | 0.745 | 0.003 ± 0.011 | 0.939 | 0.012 ± 0.012 | 0.614 | 0.013 ± 0.013 | 0.468 | |
Placebo | 34 | −0.001 ± 0.011 | 0.002 ± 0.009 | 0.020 ± 0.011 | 0.000 ± 0.011 |
Note: A significant difference (p < 0.05) in average wrinkle depth was found at the spot 10-mm from the corner of the eye at 12 weeks, (unpaired Student’s t-test between the two groups).